Impact of Neuropsychological Alteration of Decision-making Abilities on the Functioning of Patients With Eating Disorders
Impact of Neuropsychological Alteration of Decision-making Abilities on the Functioning of Patients With Eating Disorders
Eating disorders are multifactorial disorders currently conceptualized in a biopsychosocial
 model, but pathophysiology remains relatively unknown, and robust etiological models to guide
 treatment are therefore lacking. Different endophenotypes and neurocognitive vulnerability
 factors have been found in eating disorders including decision making abnormalities. The
 investigators hypothesize that decision making abnormalities are associated with a lower
 level of functioning and quality of life which could lead to social and interpersonal
 difficulties. The investigators also hypothesize that these anomalies are associated with a
 particular clinical profile (more restrictive profile, more hyperactivity, less insight on
 the disease and desire for care ...).
The investigators will recruit a total of 340 patients with an eating disorder in the
 university hospital of Montpellier.

 -  Participation consists of a one-day visit with a multidisciplinary assessment. No action
 is specific to research. This is the usual management of patients with eating disorders
 addressed to our department.

 -  An ancillary study will be proposed, if the patient is addressed by his general
 practitioner for an annual evaluation. This second visit will be exactly the same as the
 initial visit.
Inclusion Criteria:

 -  Patient with an eating disorder according to Diagnostic and Statistical Manuel of
 Mental disorders-V (DSM-V) criteria

 -  Patient aged from 15 to 65 years

 -  Patient who performs the day-hospital evaluation

 -  Patient affiliated to a French social security system

 -  Patient able to understand the nature, the aim and the methodology of the study

 -  For minor one of the legal guardians gave his consent

 Exclusion Criteria:

 -  Patient in an unstable somatic state (eg severe metabolic disorder making impossible
 or unreliable neuropsychological assessments)

 -  Patient's refusal to participate

 -  Patient on protective measures (guardianship or trusteeship)

 -  Pregnant or nursing women. A dosage of beta human chorionic gonadotropin (βHCG) will
 be performed to ensure the absence of pregnancy.